Results 141 to 150 of about 208,828 (307)

Advances in targeting histone deacetylase for treatment of solid tumors

open access: yesJournal of Hematology & Oncology
Histone deacetylase (HDAC) serves as a critical molecular regulator in the pathobiology of various malignancies and have garnered attention as a viable target for therapeutic intervention.
Mu-Qi Shi   +6 more
doaj   +1 more source

Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors [PDF]

open access: hybrid, 2022
L Bamberg   +15 more
openalex   +1 more source

The Broad Spectrum HDAC Inhibitor PCI-24781 Induces Caspase- and ROS-Dependent Apoptosis and is Synergistic with Bortezomib in Lymphoma [PDF]

open access: yes, 2008
We investigated the cytotoxicity and biology of the novel broad-spectrum hydroxamic acid-based histone deacetylase inhibitor (HDACi), PCI-24781. PCI-24781 was studied alone and combined with bortezomib in Hodgkin lymphoma (L428) and non-Hodgkin's ...
Andrew Evens   +9 more
core   +1 more source

Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models [PDF]

open access: bronze, 2008
Shuzhen Liu   +4 more
openalex   +1 more source

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.

open access: yesInternational Journal of Radiation Oncology, Biology, Physics, 2015
A. Krauze   +8 more
semanticscholar   +1 more source

Histone Deacetylase Inhibitors in Cancer

open access: diamond, 2018
Abdulrahman Mawadh A Alsubhi   +1 more
openalex   +1 more source

Intra-articular Histone Deacetylase Inhibitor Microcarrier Delivery to Reduce Osteoarthritis. [PDF]

open access: yesNano Lett, 2023
Ye J   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy